Insider · CIK 0001465837
Boxer Capital, LLC
Reports to the SEC for 14 companies · DEL MAR, CA
Transactions
50
Companies
14
Filings
8
CIK
0001465837
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-05-10 | iTeos Therapeutics, Inc.A Award | +$20M |
| 2024-02-06 | TYRATyra Biosciences, Inc. · Warrant (right to purchase)A Award | +$9.17M |
| 2024-02-06 | TYRATyra Biosciences, Inc.A Award | +$825K |
| 2024-01-23 | Mirati Therapeutics, Inc.Warrant (right to purchase)D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Warrant (right to purchase)D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Warrant (right to purchase)D Disposition to Issuer | — |
| 2023-10-16 | TNGXTango Therapeutics, Inc.P Purchase | +$3.42M |
| 2023-10-16 | TNGXTango Therapeutics, Inc.P Purchase | +$3.42M |
| 2023-10-13 | TNGXTango Therapeutics, Inc.P Purchase | +$5.3M |
| 2023-10-13 | TNGXTango Therapeutics, Inc.P Purchase | +$5.3M |
| 2023-10-09 | TNGXTango Therapeutics, Inc.S Sale | −$496K |
| 2023-10-09 | TNGXTango Therapeutics, Inc.S Sale | −$1.74M |
| 2023-08-23 | iTeos Therapeutics, Inc.S Sale | −$3.71M |
| 2023-08-23 | iTeos Therapeutics, Inc.S Sale | −$1.49M |
| 2023-08-23 | iTeos Therapeutics, Inc.S Sale | −$494K |
| 2023-08-11 | Mirati Therapeutics, Inc.P Purchase | +$33.4M |
| 2023-08-11 | Mirati Therapeutics, Inc.P Purchase | +$1.6M |
| 2023-08-11 | TNGXTango Therapeutics, Inc.A Award | +$2.45M |
| 2023-08-11 | Mirati Therapeutics, Inc.P Purchase | +$33.4M |
| 2023-08-11 | Mirati Therapeutics, Inc.P Purchase | +$1.6M |
| 2023-08-11 | TNGXTango Therapeutics, Inc. · Prefunded WarrantA Award | +$12.1M |
| 2023-08-11 | TNGXTango Therapeutics, Inc. · Prefunded WarrantP Purchase | +$12.1M |
| 2023-08-11 | TNGXTango Therapeutics, Inc.P Purchase | +$2.45M |
| 2023-05-22 | Rain Oncology Inc.S Sale | −$1.24M |
| 2022-10-13 | TNGXTango Therapeutics, Inc.P Purchase | +$325K |
| 2022-10-12 | TNGXTango Therapeutics, Inc.P Purchase | +$222K |
| 2022-10-11 | TNGXTango Therapeutics, Inc.P Purchase | +$498K |
| 2022-10-06 | TNGXTango Therapeutics, Inc.P Purchase | +$286K |
| 2022-10-05 | TNGXTango Therapeutics, Inc.P Purchase | +$179K |
| 2022-10-05 | TNGXTango Therapeutics, Inc.P Purchase | +$155K |
| 2022-10-04 | TNGXTango Therapeutics, Inc.P Purchase | +$94K |
| 2022-03-17 | iTeos Therapeutics, Inc.S Sale | −$20.3M |
| 2022-01-04 | iTeos Therapeutics, Inc.S Sale | −$340K |
| 2022-01-04 | iTeos Therapeutics, Inc.S Sale | −$1.24M |
| 2022-01-04 | iTeos Therapeutics, Inc.S Sale | −$406K |
| 2022-01-04 | iTeos Therapeutics, Inc.S Sale | −$1.48M |
| 2022-01-04 | iTeos Therapeutics, Inc.S Sale | −$136K |
| 2022-01-04 | iTeos Therapeutics, Inc.S Sale | −$114K |
| 2022-01-04 | iTeos Therapeutics, Inc.S Sale | −$3.68M |
| 2022-01-04 | iTeos Therapeutics, Inc.S Sale | −$498K |
| 2022-01-03 | iTeos Therapeutics, Inc.S Sale | −$1.11M |
| 2022-01-03 | iTeos Therapeutics, Inc.S Sale | −$20.6M |
| 2022-01-03 | iTeos Therapeutics, Inc.S Sale | −$83K |
| 2022-01-03 | iTeos Therapeutics, Inc.S Sale | −$1.95M |
| 2022-01-03 | iTeos Therapeutics, Inc.S Sale | −$870K |
Recent filings
- 4LEWIS JOSEPH0000895345-24-000172SEC(opens sec.gov)
- 4LEWIS JOSEPH0000895345-24-000035SEC(opens sec.gov)
- 4LEWIS JOSEPH0000895345-24-000019SEC(opens sec.gov)
- 4LEWIS JOSEPH0000895345-23-000588SEC(opens sec.gov)
- 4/ALEWIS JOSEPH0000895345-23-000589SEC(opens sec.gov)
- 4LEWIS JOSEPH0000895345-23-000574SEC(opens sec.gov)
- 4/ALEWIS JOSEPH0000895345-23-000573SEC(opens sec.gov)
- 4LEWIS JOSEPH0000895345-23-000524SEC(opens sec.gov)
Companies
- ARADIGM CORP10% Owner
- Carisma Therapeutics Inc.10% OwnerCARM
- Esperion Therapeutics, Inc.10% OwnerESPR
- iTeos Therapeutics, Inc.See remarks
- Mirati Therapeutics, Inc.See remarks
- Odonate Therapeutics, Inc.10% Owner
- Pandion Therapeutics, Inc.10% Owner
- Pernix Sleep, Inc.Member of 13(d) group
- PMV Pharmaceuticals, Inc.Former 10% OwnerPMVP
- Rain Oncology Inc.See remarks.
- Solid Biosciences Inc.10% OwnerSLDB
- SOPHIRIS BIO INC.10% Owner
- Tango Therapeutics, Inc.See remarksTNGX
- Tyra Biosciences, Inc.See RemarksTYRA
Address
445 MARINE VIEW AVENUE SUITE 100
DEL MAR, CA, 92014